On December 2, 2020, we entered into a Distribution Agreement with Tasnim Behboud Arman (“Distributor”) to distribute the INVOcell system to the Islamic Republic of Iran under which Distributor was appointed as the exclusive distributor in the Islamic Republic of Iran. The agreement is for an initial term of one year and can be renewed upon the mutual agreement of the parties. We also granted Distributor a non-exclusive right to the INVO trademarks in Iran in connection with the sale of products in Iran.
The foregoing summary of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INVO BIOSCIENCE, INC.
/s/ Steven Shum
Chief Executive Officer
Dated December 7, 2020
makes a similar move, sign up!
Other recent filings from the company include the following:
Notice of Effectiveness - April 16, 2021
Current report, items 1.01, 8.01, and 9.01 - April 13, 2021
Registration statement under Securities Act of 1933 - April 7, 2021
Invo Bioscience Reports 2020 Financial Results - March 30, 2021